BARDA is supporting US government market research to identify medical countermeasures with the potential to help address the 2019 novel coronavirus outbreak. The agency wants to hear from companies developing diagnostics, therapeutics, vaccines, or other products. They are asking for …
Learn MoreIO360˚addresses the rapid advancements of clinical, scientific and business developments of IO. Discount registration available for CFB constituents.
Learn MoreNew life science accelerator has launched in New York City, offering space, financing and more. Applications open and accepted until March 1, 2020.
Learn MoreCFB Client, Codagenix, has announced the closing of a $20 million Series B investment round.
Learn MoreMicroRid Technologies Inc. has received a five year, $4 million, PRMRP award.
Learn MoreASPR/BARDA is issuing a Request for Information (RFI) to assist in understanding the developmental landscape of next generation blood products.
Learn More